Creative Planning Vertex Pharmaceuticals Inc Call Options Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Jan 29, 2021	SELL	$207.01 - $276.09 $186,309 - $248,480	-900 Reduced 90.0%	100 $0
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $51,130 - $60,620	200 Added 25.0%	1,000 $128,000
Q4 2019 Jan 30, 2020	BUY	$166.71 - $223.91 $50,013 - $67,173	300 Added 60.0%	800 $63,000
Q3 2018 Oct 25, 2018	BUY	$167.73 - $192.74 $83,865 - $96,370	500 New	500 $50,000

1,624

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.